Stock Analysis
- Australia
- /
- Healthtech
- /
- ASX:M7T
ASX Penny Stocks To Watch In January 2025
Reviewed by Simply Wall St
The Australian market recently saw the ASX200 reach a record high, buoyed by positive investor sentiment and strong performances in sectors like IT, Materials, and Real Estate. Penny stocks, while often overlooked due to their smaller size or newer status, can still offer compelling opportunities for growth when backed by solid financials. As investors seek out hidden gems with potential for long-term success, these stocks present an intriguing option worth considering amidst the current market dynamics.
Top 10 Penny Stocks In Australia
Name | Share Price | Market Cap | Financial Health Rating |
Embark Early Education (ASX:EVO) | A$0.78 | A$143.12M | ★★★★☆☆ |
LaserBond (ASX:LBL) | A$0.57 | A$66.82M | ★★★★★★ |
Austin Engineering (ASX:ANG) | A$0.50 | A$310.07M | ★★★★★☆ |
MaxiPARTS (ASX:MXI) | A$1.92 | A$106.21M | ★★★★★★ |
GTN (ASX:GTN) | A$0.55 | A$108.01M | ★★★★★★ |
Helloworld Travel (ASX:HLO) | A$2.01 | A$327.26M | ★★★★★★ |
SHAPE Australia (ASX:SHA) | A$2.96 | A$245.42M | ★★★★★★ |
IVE Group (ASX:IGL) | A$2.23 | A$345.4M | ★★★★☆☆ |
Vita Life Sciences (ASX:VLS) | A$1.88 | A$104.6M | ★★★★★★ |
SKS Technologies Group (ASX:SKS) | A$1.59 | A$247.67M | ★★★★★★ |
Click here to see the full list of 1,028 stocks from our ASX Penny Stocks screener.
Let's take a closer look at a couple of our picks from the screened companies.
Jupiter Mines (ASX:JMS)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Jupiter Mines Limited is an independent mining company based in Australia with a market capitalization of A$303.96 million.
Operations: The company generates revenue from its manganese operations in South Africa, amounting to A$8.07 million.
Market Cap: A$303.96M
Jupiter Mines Limited, with a market cap of A$303.96 million, faces challenges typical of penny stocks, including negative earnings growth and declining profits over the past five years. Despite trading at 23.8% below its estimated fair value and being debt-free with sufficient short-term assets to cover liabilities, its dividend yield of 8.06% is not well supported by free cash flow. The company's return on equity is low at 7.2%, and it has experienced lower profit margins compared to last year. Additionally, the board's average tenure suggests limited experience which could impact strategic decisions.
- Click to explore a detailed breakdown of our findings in Jupiter Mines' financial health report.
- Review our historical performance report to gain insights into Jupiter Mines' track record.
Mach7 Technologies (ASX:M7T)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Mach7 Technologies Limited offers enterprise imaging data sharing, storage, and interoperability solutions for healthcare enterprises globally, with a market cap of A$98.91 million.
Operations: The company's revenue is derived from three main segments: Software Licenses (A$13.17 million), Professional Services (A$4.07 million), and Maintenance and Support (A$11.87 million).
Market Cap: A$98.91M
Mach7 Technologies, with a market cap of A$98.91 million, presents both opportunities and challenges typical of penny stocks. The company remains unprofitable but forecasts earnings growth of 71.41% per year, supported by its debt-free status and positive free cash flow providing a cash runway exceeding three years. Recent initiatives include a share repurchase program up to 10% of issued capital and the launch of UnityVue, an advanced radiology software platform enhancing diagnostic workflows through AI-driven features. While Mach7's board is experienced with an average tenure of 5.6 years, its management team is relatively new with only two years on average in their roles.
- Click here to discover the nuances of Mach7 Technologies with our detailed analytical financial health report.
- Explore Mach7 Technologies' analyst forecasts in our growth report.
OFX Group (ASX:OFX)
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: OFX Group Limited offers international payments and foreign exchange services across the Asia Pacific, North America, Europe, the Middle East, and Africa with a market cap of A$330.15 million.
Operations: The company's revenue is derived from the Asia Pacific region (A$91.22 million), North America (A$88.75 million), and Europe (A$36.80 million).
Market Cap: A$330.15M
OFX Group, with a market cap of A$330.15 million, offers a mix of strengths and weaknesses typical in the penny stock arena. The company has demonstrated stable financial management, with short-term assets exceeding both short- and long-term liabilities. Despite recent negative earnings growth and declining net profit margins, OFX's earnings are forecast to grow by 20.21% annually. The firm has completed significant share buybacks, indicating confidence in its valuation which is currently seen as undervalued by analysts. Additionally, its debt is well-managed with more cash than total debt and strong interest coverage from EBIT.
- Jump into the full analysis health report here for a deeper understanding of OFX Group.
- Gain insights into OFX Group's future direction by reviewing our growth report.
Key Takeaways
- Get an in-depth perspective on all 1,028 ASX Penny Stocks by using our screener here.
- Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.
- Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent.
Seeking Other Investments?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Jump on the AI train with fast growing tech companies forging a new era of innovation.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About ASX:M7T
Mach7 Technologies
Provides enterprise imaging data sharing, storage, and interoperability for healthcare enterprises in North America, the Asia Pacific, the Middle East, Europe, and internationally.